Company Filing History:
Years Active: 1987
Title: Michel De Wilde: Innovator in Recombinant DNA Technology
Introduction
Michel De Wilde is a notable inventor based in Rixensart, Belgium. He has made significant contributions to the field of biotechnology, particularly in the area of recombinant DNA technology. His work has implications for medical research and the development of vaccines.
Latest Patents
Michel De Wilde holds a patent related to DNA sequences and recombinant DNA molecules. This patent involves processes for producing DNA sequences and recombinant DNA molecules that code for subunits A and/or B of cholera toxin. The method includes enzymatic digestion of DNA from V. cholerae strains, isolating specific fragments, and inserting them into appropriate vectors. The subunits A and/or B of cholera toxin are then prepared by culturing microorganisms containing these modified vectors. He has 1 patent to his name.
Career Highlights
Throughout his career, Michel has worked at SmithKline-RIT, where he has been involved in groundbreaking research and development projects. His expertise in recombinant DNA technology has positioned him as a valuable asset in the field of biotechnology.
Collaborations
Michel has collaborated with various professionals in his field, including his coworker Nigel Harford. Their combined efforts have contributed to advancements in recombinant DNA research.
Conclusion
Michel De Wilde's innovative work in recombinant DNA technology showcases his commitment to advancing scientific knowledge and improving public health. His contributions continue to influence the field of biotechnology.